Rodney Varner Email and Phone Number

Responsible for all major Urology, Gynecologic Oncology and Hematology/Oncology accounts in the Cincinnati, Dayton and Northern KY Areas. These accounts include, but are not limited to, University of Cincinnati, The Urology Group, Oncology Hematology Care, Kettering Physicians, TriHealth, etc... Successfully launched Lynparza for Prostate Cancer. Currently maintain and grow prescribers for Prostate and Ovarian Cancers.2020 - Finished 4th out of 48 during launch year 2023 - Finished Top 10 out of 82

Spearheaded the launch of Venclexta, the first BCL-2 inhibitor in 17P- CLL. For past 2 years have covered the state of Indiana, Cincinnati and Dayton, OH. For the 5 years prior to that, I successfully drove Rituxan and Gazyva market share in FL, DLBCL, and CLL in Southern Ohio.

Responsible for meeting or exceeding sales goals for Taxotere in Breast, Prostate, Gastric, and Head and Neck cancers.

Exceeded sales goals in a variety of Specialty Sales roles during my tenor at Searle - Urology, Psychiatry, Orthopedics, and Rheumatology.- Corporate Internship Program- Completed Management Career Development Center- District Trainer several years